Amazon Pharmacy Expands $50/Month GLP-1 Access for Medicare Patients, Targets 4,500 US Cities by 2026

Amazon Pharmacy announced Thursday, August 6, 2026, that it joined the federal Medicare GLP-1 Bridge Program. Eligible Medicare Part D patients can now access GLP-1 medications for a flat $50 monthly copay. The program covers Wegovy, Zepbound, and Foundayo, with free home delivery included. Amazon Pharmacy currently serves over 3,100 US cities, expanding toward 4,500 by year-end.

Amazon Pharmacy Joins Medicare GLP-1 Bridge Program

The Centers for Medicare & Medicaid Services launched this Bridge Program on July 1, 2026. Amazon (NASDAQ: AMZN) Pharmacy now participates as an authorized pharmacy under this federal initiative.

• Flat $50 monthly copay for eligible Medicare Part D members
• Covers Wegovy, Zepbound KwikPen, and Foundayo prescriptions
• Amazon handles eligibility verification, prior authorization, and billing automatically

Patients simply add their Bridge insurance plan and Medicare ID to get started. This removes much of the paperwork burden typically associated with specialty medication access nationwide.

Amazon Pharmacy’s $50 GLP-1 Pricing: What’s Included

Amazon Pharmacy offers both home delivery and in-office kiosk pickup at select One Medical locations. Newly approved oral GLP-1 pills are also dispensed through these same physical kiosks.

• Manufacturer-sponsored coupons have saved customers over $300 million to date
• Prime Rx offers savings up to 80% on medications for members
• Caregiver support lets trusted individuals manage prescriptions through their own account

Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) manufacture these GLP-1 medications distributed through Amazon Pharmacy’s expanding network.

Delivery Expansion Targets 4,500 Cities

Same-day delivery currently reaches more than 3,100 US cities and towns nationwide. Amazon Pharmacy plans to expand that same-day footprint to nearly 4,500 locations by the end of 2026.

• No Prime membership required for Bridge Program participation
• RxPass offers 60 generic medications for $5 monthly, separately from GLP-1 coverage
• Coverage now spans all 50 states with standard shipping options too

Competitive Pressure Builds in the GLP-1 Market

Major retailers are racing to capture market share as GLP-1 prescriptions surge nationwide. Obesity affects more than 40% of US adults, driving sustained demand across this drug category.

• CVS Health also participates in the Medicare Bridge Program
• Walmart and Costco are expanding their own GLP-1 pharmacy offerings
• Amazon acquired One Medical in 2022 to support this integrated care model

Amazon.com continues positioning its pharmacy division as a full-service weight-management provider. This combines primary care, prescription fulfillment, and delivery logistics under one unified platform.

Bottom Line

Amazon Pharmacy’s expanded Medicare GLP-1 access reflects broader competition among retail giants chasing this fast-growing drug category. The $50 flat copay, paired with rapid delivery expansion, positions Amazon competitively against CVS, Walmart, and Costco. Success will likely depend on execution speed as Amazon races toward its 4,500-city delivery target. Medicare beneficiaries now have another affordable pathway to access these in-demand weight-loss medications.

Disclaimer:

The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.